Page 4 - Cell Technologies News Today

Tesla PLI Scheme: In 2022, the Centre had awarded PLI support for setting up 30 GWh of ACC battery manufacturing capacity by 2030. Ola Cell Technologies won the lion’s share with 20 GWh capacity in their kitty. ACC Energy Storage (bid as Rajesh Exports) and Reliance New Energy Battery Storage were awarded incentives for 5 GWh each. The government expects PLI incentives will help these three players set up GWh of battery manufacturing capacity.

Terumo (OTCMKTS:TRUMY – Get Free Report) issued its earnings results on Wednesday. The company reported $0.27 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.27, MarketWatch Earnings reports. The firm had revenue of $1.62 billion for the quarter. Terumo had a net margin of 11.47% and a return on equity of […]

The Heavy Industries Ministry has started reauction for 10 GWh of Production Linked Incentives (PLI) for Advanced Chemistry Cell (ACC) manufacturing. The incentives will support manufacturing of Electric Vehicle (EV) batteries. A budgetary outlay of Rs 3,620 crore has been earmarked as incentives against setting up this battery manufacturing capacity. In addition, a separate round of bids will be called for another 10 GWh of incentives for stationery battery applications. The 20 GWh PLI capacity...

We caught up with Kevin Knopp, CEO and co-founder of 908 Devices, to discuss the main obstacles in cell and gene therapy manufacturing and how the company's recent partnership with Terumo Blood and Cell Technologies is tackling these challenges.

December 05, 2023 See how an Austrian police officer fighting leukemia is helped by a stem cell donation from his sister - just one way that apheresis technology helps...

DUBLIN--(BUSINESS WIRE)--The "Stem Cell Technologies and Applications Market Report 2023-2033" has been added to ResearchAndMarkets.com's offering.World revenue for the Stem Cell Technologies and Applications Market is forecast to surpass US$10 billion in 2023.Growing government support for stem cell research and de...

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The

Therapeutic Apheresis IndustryAccording to forecasts, the therapeutic apheresis industry is expected to be US$ 2,717.9 million in 2023 and US$ 5,264.4 million by 2033, the demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period.The rising prevalence of diseases, increased d...

IO Biotech, Quotient Sciences and Terumo Blood and Cell Technologies are among the key companies welcoming new colleagues.

- Funding of up to EUR 177 million for EKPO granted by the federal and state governments as part of the European IPCEI Hydrogen program until 2027 - Funding to be used to expand...